Alexi A. Wright, MD, MPH
Assistant Professor of Medicine, Harvard Medical School
Office phone: 617-632-2334
Preferred contact method: appointment phone
View Physician Profile
Cervical cancer, Ovarian cancer, Gynecologic cancers, Quality of life, End-of-life care
Area of Research
Health services, comparative effectiveness, intervention research, genomics
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Dr. Wright is an Assistant Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute. She received her Medical Degree from University of Pennsylvania and completed a residency in Internal Medicine at Brigham and Women’s Hospital and an Medical Oncology fellowship at Dana-Farber Cancer Institute. She also obtained a Masters in Public Health at the Harvard School of Public Health. In 2009 she joined the faculty of Dana-Farber Cancer Institute, where she is a practicing medical oncologist who specializes in gynecologic oncology and health outcomes research.
- American Cancer Society Mentored Research Scholar Grant, 2013
- National Cancer Institute K07 Career Development Award, 2013
- American Society for Clinical Oncology Career Development Award , 2010
- National Palliative Care Research Center Career Development Award, 2010
- American Society of Clinical Oncology Young Investigator Award, 2009
- Wellness Community "Outstanding Caregiver Award", 2007
- Brigham and Women's Hospital's Award for "Distinguished Resident Mentor", 2006
- Brigham and Women's Hospital's "Dunne Award for Compassionate Clinical Care", 2003
ResearchHealth services, comparative effectiveness, intervention research, genomics
My research examines the ways that communication between physicians and patients shape advanced cancer patients' understanding of their disease, treatment decisions, and medical outcomes. I am developing interventions to improve patient-physician communication, ensure that patients' care is congruent with their values, and improves patients' quality of life. I also have a specific interest in cervical cancer and examining how genomic alterations influence patient outcomes at a population-level.
- Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, Mitchell SL, Jackson VA, Block SD, Maciejewski PK, Prigerson HG. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300(14):1665-73.
- Wright AA, Mack JW, Kritek PA, Balboni TA, Massaro AF, Matulonis UA, Block SD, Prigerson HG. Influence of patients’ preferences and treatment site on cancer patients’ end-of-life care. Cancer. 2010. 116(19):4656-63.
- Wright AA, Stieglitz H, Kupersztoch YM, Paulk ME, Kim YY, Katz IT, Munoz F, Jimenez RB, Mutchler J, Rivera L, Back AL, Prigerson HG. United States acculturation and cancer patients’ end-of-life care. PLoS One. 2013;8(3):e58663.
- Wright AA, Howitt BE, Myers AP, Dahlberg SE, Palescandolo E, Van Hummelen P, Macconaill LE, Shoni M, Wagle N, Jones RT, Quick CM, Laury A, Katz IT, Hahn WC, Matulonis UA, Hirsch MS. Oncogenic mutations in cervical cancer: Genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix. Cancer. 2013 Nov 1;119(21):3776-83. Epub 2013 Aug 23.
- Wright AA, Zhang B, Keating NL, Weeks JC, Prigerson HG. Associations between palliative chemotherapy and adult cancer patients’ end of life care and place of death: prospective cohort study. (In press, BMJ 2014)